HRT Financial’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53K Buy
+25,163
New +$48.8K ﹤0.01% 3447
2025
Q1
Sell
-20,034
Closed -$30K 2601
2024
Q4
$30K Buy
+20,034
New +$32.6K ﹤0.01% 2158
2024
Q2
Sell
-180,268
Closed -$465K 2314
2024
Q1
$465K Buy
180,268
+164,050
+1,012% +$382K ﹤0.01% 1302
2023
Q4
$32K Buy
+16,218
New +$14.2K ﹤0.01% 1996
2022
Q4
Sell
-25,020
Closed -$16K 2530
2022
Q3
$16K Buy
+25,020
New +$35.3K ﹤0.01% 2500
2022
Q1
Sell
-126,782
Closed -$545K 3175
2021
Q4
$545K Buy
+126,782
New +$686K ﹤0.01% 1685
2021
Q2
Sell
-15,180
Closed -$130K 2918
2021
Q1
$130K Buy
+15,180
New +$168K ﹤0.01% 2415

Other funds holding CGEN

HRT Financial's CGEN Position: Q1 2026 in Review

HRT Financial opened a new position in Compugen (CGEN) in Q1 2026: 25,163 shares worth $53K. The stake represents ﹤0.01% of the portfolio and ranks #3447 among its holdings. This is a return to the name: HRT Financial previously reported a position in CGEN as recently as Q4 2024.

HRT Financial first reported a position in CGEN in Q1 2021 and has held it in 7 quarters since. The position peaked at $545K in Q4 2021. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

  • HRT Financial held 25,163 shares of Compugen worth $53K as of Q1 2026.
  • Compugen was a new HRT Financial position in Q1 2026.
  • Compugen made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3447 holding.
  • HRT Financial first reported a position in Compugen in Q1 2021 and has held it in 7 quarters since.
  • HRT Financial's Compugen position peaked at $545K in Q4 2021.
  • 78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.